These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38670860)

  • 1. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
    Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
    Clin Breast Cancer; 2024 Aug; 24(6):e519-e527. PubMed ID: 38670860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
    Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
    BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
    PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and genetic features in patients coexisting primary breast and thyroid cancers.
    Fu J; He M; Wu Q; Zhang X; Qi X; Shen K; Wang X; Zhang G
    Front Endocrinol (Lausanne); 2023; 14():1136120. PubMed ID: 37229458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Possible Association Between Thyroid Cancer and Breast Cancer.
    An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ
    Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin suppression therapy using levothyroxine does not negatively affect breast cancer prognosis.
    He X; Zhong M; Zhang Q; Aierken N; Cui L; Xing Z; Lei K
    Cancer Treat Res Commun; 2022; 31():100525. PubMed ID: 35114502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    Cheng W; Shen X; Xing M
    PLoS One; 2019; 14(10):e0221093. PubMed ID: 31644578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
    Zhang L; Wu Y; Liu F; Fu L; Tong Z
    Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
    Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
    Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database.
    Zhong M; He X; Lei K
    Adv Ther; 2020 May; 37(5):2236-2245. PubMed ID: 32274747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
    Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
    BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of breast cancer as the first or second primary cancer on the prognosis of women with thyroid cancer: a SEER database analysis.
    Huang J; Huang Y; Zhou L; Chen S; Chen D; Wei W; Zhang C; Wang M; Zhou W; Zeng W; Liu Z; Guo L
    Transl Cancer Res; 2020 Nov; 9(11):6955-6962. PubMed ID: 35117303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease.
    Garner CN; Ganetzky R; Brainard J; Hammel JP; Berber E; Siperstein AE; Milas M
    Surgery; 2007 Dec; 142(6):806-13; discussion 813.e1-3. PubMed ID: 18063060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.
    Huang NS; Chen XX; Wei WJ; Mo M; Chen JY; Ma B; Yang SW; Xu WB; Wu J; Ji QH; Guo XM; Liu GY; Shao ZM; Wang Y
    Cancer Med; 2018 Dec; 7(12):6393-6400. PubMed ID: 30480382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
    Zhai J; Kong XY; Fang Y; Wang J
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
    Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
    Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
    Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
    Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.